Skip to main content
Erschienen in: Supportive Care in Cancer 3/2020

11.06.2019 | Original Article

Mind-body medicine use by women diagnosed with breast cancer: results of a nationally representative survey

verfasst von: Petra Voiß, Melanie Désirée Höxtermann, Gustav Dobos, Holger Cramer

Erschienen in: Supportive Care in Cancer | Ausgabe 3/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Worldwide breast cancer is the most commonly diagnosed cancer in women and often associated with a profound physiological stress reaction. Mind-body medicine modalities have been proven effective in reducing stress symptoms. This article will cover the prevalence of MBM use in women with and without breast cancer in the US population and detect predictors of MBM use in women diagnosed with breast cancer.

Methods

The 2017 National Health Interview Survey (NHIS) was used to study the prevalence of breast cancer and the use of mind-body medicine (MBM) among individuals with breast cancer in the US population. Using chi-squared tests and backward stepwise multiple logistic regression analyses, predictors of MBM use in women with breast cancer in the past 12 months were identified.

Results

The prevalence of breast cancer in women was 3.1%. Among women diagnosed with breast cancer, 25.2% had used MBM in the past 12 months. Spiritual meditation (14.3%), followed by yoga (9.6%), and mindfulness meditation (4.3%) were the most commonly used MBM approaches for women with breast cancer diagnosis. Only higher education independently predicted the use of MBM among them.

Conclusions

In this nationally representative sample of the USA, the most common used MBM approach was spiritual meditation, while this approach is much less researched than the evidence based approaches of yoga and mindfulness meditation. Especially stressed individuals worldwide could benefit from MBM the literature suggests. Particularly in the acute survivorship stage, influencing the initial stress reaction could be beneficial.
Literatur
3.
Zurück zum Zitat Howlader N, Noone A, Krapcho M, Miller D, Bishop K, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds) (2017) SEER cancer statistics review, 1975-2014. National Cancer Institute Howlader N, Noone A, Krapcho M, Miller D, Bishop K, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds) (2017) SEER cancer statistics review, 1975-2014. National Cancer Institute
4.
Zurück zum Zitat Andrykowski MA, Cordova MJ, Studts JL, Miller TW (1998) Posttraumatic stress disorder after treatment for breast cancer: prevalence of diagnosis and use of the PTSD checklist-civilian version (PCL-C) as a screening instrument. J Consult Clin Psychol 66(3):586–590CrossRefPubMed Andrykowski MA, Cordova MJ, Studts JL, Miller TW (1998) Posttraumatic stress disorder after treatment for breast cancer: prevalence of diagnosis and use of the PTSD checklist-civilian version (PCL-C) as a screening instrument. J Consult Clin Psychol 66(3):586–590CrossRefPubMed
7.
Zurück zum Zitat Santos MC, Horta BL, Amaral JJ, Fernandes PF, Galvao CM, Fernandes AF (2009) Association between stress and breast cancer in women: a meta-analysis. Cad Saude Publica 25(Suppl 3):S453–S463CrossRefPubMed Santos MC, Horta BL, Amaral JJ, Fernandes PF, Galvao CM, Fernandes AF (2009) Association between stress and breast cancer in women: a meta-analysis. Cad Saude Publica 25(Suppl 3):S453–S463CrossRefPubMed
9.
Zurück zum Zitat Yang EV, Glaser R (2002) Stress-induced immunomodulation and the implications for health. Int Immunopharmacol 2(2–3):315–324CrossRefPubMed Yang EV, Glaser R (2002) Stress-induced immunomodulation and the implications for health. Int Immunopharmacol 2(2–3):315–324CrossRefPubMed
12.
15.
Zurück zum Zitat Lyman GH, Greenlee H, Bohlke K, Bao T, DeMichele AM, Deng GE, Fouladbakhsh JM, Gil B, Hershman DL, Mansfield S, Mussallem DM, Mustian KM, Price E, Rafte S, Cohen L (2018) Integrative therapies during and after breast cancer treatment: ASCO endorsement of the SIO clinical practice guideline. J Clin Oncol Off J Am Soc Clin Oncol 36(25):2647–2655. https://doi.org/10.1200/jco.2018.79.2721 CrossRef Lyman GH, Greenlee H, Bohlke K, Bao T, DeMichele AM, Deng GE, Fouladbakhsh JM, Gil B, Hershman DL, Mansfield S, Mussallem DM, Mustian KM, Price E, Rafte S, Cohen L (2018) Integrative therapies during and after breast cancer treatment: ASCO endorsement of the SIO clinical practice guideline. J Clin Oncol Off J Am Soc Clin Oncol 36(25):2647–2655. https://​doi.​org/​10.​1200/​jco.​2018.​79.​2721 CrossRef
18.
Zurück zum Zitat Lengacher CA, Reich RR, Paterson CL, Ramesar S, Park JY, Alinat C, Johnson-Mallard V, Moscoso M, Budhrani-Shani P, Miladinovic B, Jacobsen PB, Cox CE, Goodman M, Kip KE (2016) Examination of broad symptom improvement resulting from mindfulness-based stress reduction in breast cancer survivors: a randomized controlled trial. J Clin Oncol Off J Am Soc Clin Oncol 34(24):2827–2834. https://doi.org/10.1200/jco.2015.65.7874 CrossRef Lengacher CA, Reich RR, Paterson CL, Ramesar S, Park JY, Alinat C, Johnson-Mallard V, Moscoso M, Budhrani-Shani P, Miladinovic B, Jacobsen PB, Cox CE, Goodman M, Kip KE (2016) Examination of broad symptom improvement resulting from mindfulness-based stress reduction in breast cancer survivors: a randomized controlled trial. J Clin Oncol Off J Am Soc Clin Oncol 34(24):2827–2834. https://​doi.​org/​10.​1200/​jco.​2015.​65.​7874 CrossRef
19.
Zurück zum Zitat Molassiotis A, Fernadez-Ortega P, Pud D, Ozden G, Scott JA, Panteli V, Margulies A, Browall M, Magri M, Selvekerova S, Madsen E, Milovics L, Bruyns I, Gudmundsdottir G, Hummerston S, Ahmad AM, Platin N, Kearney N, Patiraki E (2005) Use of complementary and alternative medicine in cancer patients: a European survey. Ann Oncol 16(4):655–663. https://doi.org/10.1093/annonc/mdi110 CrossRefPubMed Molassiotis A, Fernadez-Ortega P, Pud D, Ozden G, Scott JA, Panteli V, Margulies A, Browall M, Magri M, Selvekerova S, Madsen E, Milovics L, Bruyns I, Gudmundsdottir G, Hummerston S, Ahmad AM, Platin N, Kearney N, Patiraki E (2005) Use of complementary and alternative medicine in cancer patients: a European survey. Ann Oncol 16(4):655–663. https://​doi.​org/​10.​1093/​annonc/​mdi110 CrossRefPubMed
23.
Zurück zum Zitat Barnes PM, Powell-Griner E, McFann K, Nahin RL (2004) Complementary and alternative medicine use among adults: United States, 2002. Adv Data 343:1–19 Barnes PM, Powell-Griner E, McFann K, Nahin RL (2004) Complementary and alternative medicine use among adults: United States, 2002. Adv Data 343:1–19
28.
Zurück zum Zitat Lin KY, Hu YT, Chang KJ, Lin HF, Tsauo JY (2011, 2011) Effects of yoga on psychological health, quality of life, and physical health of patients with cancer: a meta-analysis. Evid Based Complement Alternat Med 659876–659812. https://doi.org/10.1155/2011/659876 Lin KY, Hu YT, Chang KJ, Lin HF, Tsauo JY (2011, 2011) Effects of yoga on psychological health, quality of life, and physical health of patients with cancer: a meta-analysis. Evid Based Complement Alternat Med 659876–659812. https://​doi.​org/​10.​1155/​2011/​659876
30.
Zurück zum Zitat Speca M, Carlson LE, Goodey E, Angen M (2000) A randomized, wait-list controlled clinical trial: the effect of a mindfulness meditation-based stress reduction program on mood and symptoms of stress in cancer outpatients. Psychosom Med 62(5):613–622CrossRefPubMed Speca M, Carlson LE, Goodey E, Angen M (2000) A randomized, wait-list controlled clinical trial: the effect of a mindfulness meditation-based stress reduction program on mood and symptoms of stress in cancer outpatients. Psychosom Med 62(5):613–622CrossRefPubMed
33.
Zurück zum Zitat Antoni MH, Lehman JM, Kilbourn KM, Boyers AE, Culver JL, Alferi SM, Yount SE, McGregor BA, Arena PL, Harris SD, Price AA, Carver CS (2001) Cognitive-behavioral stress management intervention decreases the prevalence of depression and enhances benefit finding among women under treatment for early-stage breast cancer. Health Psychol 20(1):20–32CrossRefPubMed Antoni MH, Lehman JM, Kilbourn KM, Boyers AE, Culver JL, Alferi SM, Yount SE, McGregor BA, Arena PL, Harris SD, Price AA, Carver CS (2001) Cognitive-behavioral stress management intervention decreases the prevalence of depression and enhances benefit finding among women under treatment for early-stage breast cancer. Health Psychol 20(1):20–32CrossRefPubMed
34.
Zurück zum Zitat Stagl JM, Bouchard LC, Lechner SC, Blomberg BB, Gudenkauf LM, Jutagir DR, Gluck S, Derhagopian RP, Carver CS, Antoni MH (2015) Long-term psychological benefits of cognitive-behavioral stress management for women with breast cancer: 11-year follow-up of a randomized controlled trial. Cancer 121(11):1873–1881. https://doi.org/10.1002/cncr.29076 CrossRefPubMed Stagl JM, Bouchard LC, Lechner SC, Blomberg BB, Gudenkauf LM, Jutagir DR, Gluck S, Derhagopian RP, Carver CS, Antoni MH (2015) Long-term psychological benefits of cognitive-behavioral stress management for women with breast cancer: 11-year follow-up of a randomized controlled trial. Cancer 121(11):1873–1881. https://​doi.​org/​10.​1002/​cncr.​29076 CrossRefPubMed
Metadaten
Titel
Mind-body medicine use by women diagnosed with breast cancer: results of a nationally representative survey
verfasst von
Petra Voiß
Melanie Désirée Höxtermann
Gustav Dobos
Holger Cramer
Publikationsdatum
11.06.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
Supportive Care in Cancer / Ausgabe 3/2020
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-019-04914-x

Weitere Artikel der Ausgabe 3/2020

Supportive Care in Cancer 3/2020 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.